Mark DuerkopFeb 94 minIndustry 4.0: Where are we, and how to accelerate the transition?Strategies to faster implement pharma 4.0 concepts in biopharmaceutical industry using advanced data storing platform and hybrid modeling
Mark DuerkopJul 28, 20212 minAntleron and Novasign to join forces in ATMP ModelingAntleron and Novasign announce their collaboration in developing advanced process modeling strategies for ATMP manufacturing.
Maximilian KripplOct 18, 20192 minThe Hybrid Modeling Summer School 2019From the 25th to the 27th of September, Novasign co-hosted the 4th hybrid modeling summer school in Lisbon, Portugal. After a very...
Maximilian KripplApr 9, 20192 minNovasign at the Vienna City Marathon 2019Last Sunday, we participated in the 36th Vienna City Marathon (VCM). The VCM takes place each spring since 1984 and is Austria’s biggest...
Mark DuerkopMar 27, 20192 minBioprocessing Europe LisbonLast week we have been to Bioprocessing Europe in Lisbon. The conference was organized in a brought manner, offering both, an up- and...
Mark DuerkopNov 7, 20183 minReducing the costs of biopharmaceuticals: a bioprocess development approach In 2018 the generated revenue by biopharmaceuticals is estimated to be approximately 200 b$! Although this is an incredibly high number,...
